NeuroEM Therapeutics made headlines in September 2019 with an early-stage study suggesting its...
Israeli health tech firms merge to advance AI-powered biomarkers
Israel-based artificial intelligence (AI) startups Beyond Verbal and Healthymize, which both make diagnoses through voice analyses, have merged operations to create an entity, Vocalis Health.
Cochlear obtains FDA approval for bone conduction implant
Australia-based Cochlear has received clearance from the US Food and Drug Administration (FDA) for its Osia 2 implantable bone conduction hearing system.
FDA approves Aptar’s acute repetitive seizures treatment device
The US Food and Drug Administration (FDA) has approved Aptar Group’s Unidose Liquid System to treat acute repetitive seizures in those with epilepsy.
C2N Diagnostics reports positive results for Alzheimer’s blood test
C2N Diagnostics has reported positive results from the clinical study that evaluated APTUS-Aβ blood test’s accuracy in detecting pathology of Alzheimer’s disease in the brain.
Reversing Alzheimer’s-related memory loss with electromagnetic waves
NeuroEM Therapeutics made headlines in September 2019 with an early-stage study suggesting its MemorEM head device could reverse memory loss in Alzheimer’s disease patients. Could these encouraging results translate into an effective wearable device to treat the devastating chronic condition?
Lantheus and CarThera to use microbubbles for glioblastoma treatment
US-based Lantheus Holdings has entered into a strategic partnership with France-based CarThera to expand the use of its microbubbles for treatment of glioblastoma, an aggressive form of brain cancer.
Debate over reuse of single-use medical devices rages on
In many countries around the world, medical centres are combining the lower per-unit prices of single-use devices with the reduced costs associated with device reuse by reusing single-use devices.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.